Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)

Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.